Kyle Judd, MD
Orthopaedic Trauma · Rochester, NYNPI 1093923468
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,750 of the $6,078 with a category attached, or 61.7%. Synthes GmbH accounts for 90.1% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $5,476 and has fallen 96.7% since, to $179 in 2025. That places this record below the midpoint for orthopaedic trauma clinicians in NY, where the typical reported total is $6,990.
Across 10 payments — averaging $607.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$5K
- Stryker$291
- Zimmer Biomet$144
- Smith+Nephew$132
- Boston Scientific$35
Across 16 payments — averaging $1771.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- DJO, LLC$28K
What the payments were for
- Speaking & faculty fees$3,75062%
- Travel & lodging$1,57126%
- Food & beverage$75712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 4 | $5,476 |
| Stryker | 3 | $291 |
| Zimmer Biomet | 1 | $144 |
| Smith+Nephew | 1 | $132 |
| Boston Scientific | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRIATHLON$171
- Affixus$144
- Navio Surgical System$132
How this compares
$6,078 in reported general payments places this provider in the 40th percentile of 44 orthopaedic trauma providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Rochester
- Justin VaidaRochester$35K
- Noah JosephRochester$16K
- Sarah RizzoRochester$13K
- John KetzRochester$3K
- Catherine HumphreyRochester$729
- John GorczycaRochester$159
- Mackenzie NeumaierRochester$119
- David HelfetNew York$265K
- Philipp LeuchtNew York$260K
- Matthew SullivanEast Syracuse$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.